These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39093553)

  • 1. Evaluation of rat and rabbit embryofetal development studies with pharmaceuticals: the added value of a second species.
    Roos P; Anggasta C; Piersma AH; van Meer PJK; Theunissen PT
    Crit Rev Toxicol; 2024 Oct; 54(9):619-633. PubMed ID: 39093553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2018 and 2019.
    Barrow P; Clemann N
    Reprod Toxicol; 2021 Jan; 99():144-151. PubMed ID: 32593570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2022 and 2023.
    Barrow P
    Reprod Toxicol; 2024 Dec; 130():108727. PubMed ID: 39332698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the reliability of 52 enhanced preliminary embryofetal development studies to detect developmental toxicity.
    Barrow P
    Birth Defects Res; 2023 Jan; 115(2):218-223. PubMed ID: 36331145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing developmental toxicity in a second species: are the differences due to species or replication error?
    Braakhuis HM; Theunissen PT; Slob W; Rorije E; Piersma AH
    Regul Toxicol Pharmacol; 2019 Oct; 107():104410. PubMed ID: 31226390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2016 and 2017.
    Barrow P
    Reprod Toxicol; 2018 Sep; 80():117-125. PubMed ID: 29660390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of rat and rabbit embryo-fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects.
    Theunissen PT; Beken S; Beyer BK; Breslin WJ; Cappon GD; Chen CL; Chmielewski G; De Schaepdrijver L; Enright B; Foreman JE; Harrouk W; Hew KW; Hoberman AM; Hui JY; Knudsen TB; Laffan SB; Makris SL; Martin M; McNerney ME; Siezen CL; Stanislaus DJ; Stewart J; Thompson KE; Tornesi B; Van der Laan JW; Weinbauer GF; Wood S; Piersma AH
    Crit Rev Toxicol; 2016 Nov; 46(10):900-910. PubMed ID: 27848393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a comparative retrospective analysis of rat and rabbit developmental toxicity studies for pharmaceutical compounds.
    Theunissen PT; Beken S; Cappon GD; Chen C; Hoberman AM; van der Laan JW; Stewart J; Piersma AH
    Reprod Toxicol; 2014 Aug; 47():27-32. PubMed ID: 25517003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility and developmental toxicity assessment in rats and rabbits with LY500307, a selective estrogen receptor beta (ERβ) agonist.
    Hilbish KG; Breslin WJ; Johnson JT; Sloter ED
    Birth Defects Res B Dev Reprod Toxicol; 2013 Oct; 98(5):400-15. PubMed ID: 24323950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure assessments in reproductive and developmental toxicity testing: An IQ-DruSafe industry survey on current practices and experiences in support of exposure-based high dose selection.
    Andrews PA; McNerney ME; DeGeorge JJ
    Regul Toxicol Pharmacol; 2019 Oct; 107():104413. PubMed ID: 31229519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictivity of preliminary embryo-fetal development (EFD) studies: results of a retrospective survey in Japanese pharmaceutical companies.
    Okahashi N; Ikeda T; Kai S; Komatsu S; Matsui H; Yamashita Y; Yamamoto K; Sagami F
    J Toxicol Sci; 2010 Feb; 35(1):21-31. PubMed ID: 20118621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2020 and 2021.
    Barrow P
    Reprod Toxicol; 2022 Sep; 112():100-108. PubMed ID: 35788364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of exposure margins in developmental toxicity studies for detection of human teratogens.
    Andrews PA; Blanset D; Costa PL; Green M; Green ML; Jacobs A; Kadaba R; Lebron JA; Mattson B; McNerney ME; Minck D; Oliveira LC; Theunissen PT; DeGeorge JJ
    Regul Toxicol Pharmacol; 2019 Jul; 105():62-68. PubMed ID: 30981719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of developmental toxicity studies in rat and rabbit: what is the added value of the rabbit as an additional test species?
    Janer G; Slob W; Hakkert BC; Vermeire T; Piersma AH
    Regul Toxicol Pharmacol; 2008 Mar; 50(2):206-17. PubMed ID: 18171599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of embryo-fetal developmental toxicity studies performed for recent FDA-approved pharmaceuticals.
    Ishihara-Hattori K; Barrow P
    Reprod Toxicol; 2016 Sep; 64():98-104. PubMed ID: 27112525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility and Embryo-Fetal Development Assessment in Rats and Rabbits with Evacetrapib: A Cholesteryl Ester Transfer Protein Inhibitor.
    Breslin WJ; Hilbish KG; Cannady EA; Edwards TL
    Birth Defects Res; 2017 Apr; 109(7):513-527. PubMed ID: 28398618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing rat and rabbit embryo-fetal developmental toxicity data for 379 pharmaceuticals: on systemic dose and developmental effects.
    Theunissen PT; Beken S; Beyer B; Breslin WJ; Cappon GD; Chen CL; Chmielewski G; de Schaepdrijver L; Enright B; Foreman JE; Harrouk W; Hew KW; Hoberman AM; Y Hui J; Knudsen TB; Laffan SB; Makris SL; Martin M; McNerney ME; Siezen CL; Stanislaus DJ; Stewart J; Thompson KE; Tornesi B; Van der Laan JW; Weinbauer GF; Wood S; Piersma AH
    Crit Rev Toxicol; 2017 May; 47(5):402-414. PubMed ID: 27766926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of CNTO 530, an erythropoietin mimetic-IgG4 fusion protein, on embryofetal development in rats and rabbits.
    Martin PL; Sachs C; Hoberman A; Jiao Q; Bugelski PJ
    Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):87-96. PubMed ID: 20077575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.